AccessibilityHelpAbout Us
NewGenIvf Group logo

NewGenIvf Group(NASDAQ) NIVF

Market Cap$1.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-100%
5 YearN/A
1 Year-100%
1 Month-67%
$0.52
-3.24%
-0.02Today
NewGenIvf Group last closing stock price
MetricPriceDate
Last closeUSD 0.542026-09-24
NewGenIvf Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-24.31%USD 0.712026-09-17
1 month-67.16%USD 1.652026-08-25
3 month-89.27%USD 5.042026-06-26
Year to date-99.27%USD 74.522025-12-31
1 year-99.95%USD 1,053.002025-09-24
3 year-100%USD 5,821,200.002023-09-25
Since inception-100%USD 5,308,061.992022-03-18

NewGenIvf Group Financials at a Glance

Market Cap

$1.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$5.45M

Net Income (TTM)

$9.03M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.52

Volume

45,330.677

Open

$0.53

Previous Close

$0.54

Daily Range

$0.52 - $0.55

52-Week Range

$0.52 - $1,539.00

Estimated Earnings Date

Mar 3, 2027

NIVF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NewGenIvf Group

NewGenIvf Group Limited is a healthcare company based in Bangkok, Thailand, specializing in assisted reproductive services. The firm is dedicated to providing a range of fertility treatments, including in-vitro fertilization (IVF), egg donation, and surrogacy, supported by comprehensive ancillary care.

Products and Services
  • Conventional in-vitro fertilization (IVF) services
  • Egg donation programs
  • Surrogacy arrangements and support
Growth Outlook
  • Significant increase in revenue from $1,514,455 in Q4 2023 to $1,424,554 in Q4 2025
  • Improved gross profit margin from 12.95% in Q4 2023 to 36.79% in Q4 2025
  • Strong market demand for fertility services in Southeast Asia
Financial Highlights
  • Trailing twelve months (TTM) revenue of $5,000,000
  • Net income margin of 3.38% in the latest quarter
  • Current ratio of 3.12, indicating strong liquidity
NewGenIvf Group Limited operates in a growing sector with increasing demand for fertility services. The company's recent financial performance shows a positive trend, with a notable increase in revenue and gross profit margins. The current ratio indicates a solid liquidity position, which is essential for sustaining operations and funding future growth initiatives. The firm’s commitment to providing comprehensive fertility solutions positions it well to capitalize on the expanding market in Southeast Asia.
AI Generated • Sep 22, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

76

CEO

Wing Fung Siu

Website

www.newgenivf.com

Headquarters

Bangkok, BM 10110, TH

NIVF Financials

Key Financial Metrics (TTM)

Gross Margin

23.72%

Operating Margin

-276.57%

Net Income Margin

338.20%

Return on Equity

32.69%

Return on Capital

-34.06%

Return on Assets

27.98%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.24M

Volume

45.33K

Avg. Volume

192.65K

Financials (TTM)

Gross Profit

$1.83M

Operating Income

-$8.36M

EBITDA

$9.81M

Operating Cash Flow

-$6.73M

Capital Expenditure

-$2.82K

Free Cash Flow

-$6.74M

Cash & ST Invst.

$758.62K

Total Debt

$4.86M

NewGenIvf Group Performance Analysis

NewGenIvf Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 5,136,153N/A
20242024-12-31USD 5,433,3755.8%
20252025-12-31USD 4,726,433-13.0%
NewGenIvf Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32024-09-30N/A
Q42024-12-31-13.5%
Q32025-09-30N/A
Q42025-12-3111.1%
NewGenIvf Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 11,631.60N/A
20232023-12-31USD 2,309.40-80.1%
20242024-12-31USD -4,147.20N/A
20252025-12-31USD 9.12N/A
NewGenIvf Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32024-09-30N/A
Q42024-12-31-251.9%
Q32025-09-30N/A
Q42025-12-31-145.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.42M

-6.2%

Gross Profit

$524.03K

+166.2%

Gross Margin

36.79%

N/A

Market Cap

$1.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$13.95K

N/A

Employees

87

N/A

Net Income

-$7.67M

-2385.0%

EBITDA

-$7.27M

-2099.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$758.62K

+1302.2%

Total Debt

$4.86M

+1362.6%

Accounts Receivable

$1.07M

+105.8%

Inventory

$335.36K

+165.6%

Long Term Debt

$4.37M

+3572.7%

Short Term Debt

$494.16K

+131.4%

Return on Assets

27.98%

N/A

Return on Invested Capital

-24.66%

N/A

Free Cash Flow

-$6.36M

-27903.3%

Operating Cash Flow

-$6.35M

-27890.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ZVSAZyVersa Therapeutics, Inc.
$0.10-4.89%
IVFINVO Fertility, Inc.
$0.97+3.12%
HEPAHepion Pharmaceuticals, Inc.
$0.06-26.26%
CCMConcord Medical Services Holdings Limited
$3.68+3.37%

Trending Stocks

Symbol / CompanyPricePrice Chg
GLNDGreenland Energy
$6.12+14.39%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.86-3.77%
INTCIntel
$123.37-3.16%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$32.90-2.17%

Questions About NIVF

What is the current price of NewGenIvf Group?

NewGenIvf Group is trading at $0.53 per share.

What is the 52-week range for NewGenIvf Group?

Over the past 52 weeks, NewGenIvf Group has traded between $0.52 and $1,539.00.

How much debt does NewGenIvf Group have?

As of the most recent reporting period, NewGenIvf Group reported total debt of $3.03M.

How much cash does NewGenIvf Group have on hand?

NewGenIvf Group reported $457.74K in cash and cash equivalents in its most recent financial results.

What is NewGenIvf Group’s dividend yield?

NewGenIvf Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services